CHICAGO — A Chicago children’s hospital has been forced to take its networks offline after an unspecified digital attack, limiting access to medical records and hampering communication by phone or email since the middle of last week. Lurie Children’s Hospital initially described the issue Wednesday as a network outage. On Thursday, officials released public statements … Read more
King Charles and alternative medicine approaches to cancer care The Washington Post >View original article Contributor:
Stroke: Could ginkgo biloba improve cognitive recovery? Medical News Today >View original article Contributor:
With the number of adolescents struggling with mental health rising, student-led clubs have come to provide support amid a dearth of resources. View original article Contributor: Jennifer Miller
Receiving multidose vaccinations in both arms, instead of just one, may increase the immune response, new research suggests. View original article Contributor: Apoorva Mandavilli
While Buckingham Palace released little information on Charles’s diagnosis, some cancer experts not involved in his care have seen the illness detected during other routine medical procedures. View original article Contributor: Gina Kolata
An experimental weight-loss shot from Amgen Inc.—taken less frequently than wildly popular treatments from Eli Lilly & Co. and Novo Nordisk A/S—appears to keep weight off even after patients stop taking it. Patients given a monthly injection of Amgen’s drug, dubbed MariTide, lost up to 14.5% of their body weight in just 12 weeks, according … Read more
Black people in the U.S. were far more likely to report harmfully low sleep in the months after a killing compared with white people surveyed during that time. View original article Contributor: Emily Baumgaertner
Adults treated with 14 days of intravenous injections of ginkgo diterpene lactone meglumine (GDLM) — a combination of biologically active components of ginkgo biloba — after an ischemic (clot-caused) stroke had better cognitive recovery at 14 days and 90 days. View original article Contributor:
The patients used tirzepatide, sold as Mounjaro or Zepbound, but researchers could not distinguish the effect of the drug from the effects of weight loss. View original article Contributor: Gina Kolata